🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers

RecruitingEARLY Phase 1Ages 35 Years - anyAllPak Emirates Military Hospital
NCT07294521 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included. Exclusion Criteria: * Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.
💊

What it tests

  • Platelet rich Fibrin (PRF)
📍

Where

1 site
Pak Emirates Military Hospital
Rawalpindi, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy